发明名称 TARGETED THERAPEUTIC AGENTS
摘要 Therapeutic and imaging agents which are comprised of a targeting entity, a therapeutic or treatment entity and a linking carrier are provided. The linking carrier imparts additional advantages to the therapeutic agents, which are not provided by conventional linking methods. Preferred agents of the present invention comprise a lipid construct, vesicle, liposome, or polymerized liposome. In some cases, the therapeutic or treatment entity is a radioisotope, chemotherapeutic agent, prodrug, toxin, or gene encoding a protein that exhibits cell toxicity. Preferably, the agent is further comprised of a stabilizing entity that imparts additional advantages to the therapeutic or imaging agent.
申请公布号 KR20030038814(A) 申请公布日期 2003.05.16
申请号 KR20037005116 申请日期 2003.04.11
申请人 发明人
分类号 A61K9/127;A61K51/00;A61K31/7052;A61K45/00;A61K47/30;A61K47/34;A61K47/36;A61K47/42;A61K49/00;A61K49/16;A61K49/18;A61K51/10;A61K51/12;A61P1/02;A61P17/06;A61P19/02;A61P19/10;A61P21/00;A61P27/02;A61P29/00;A61P31/04;A61P31/12;A61P35/00;A61P35/04;A61P43/00 主分类号 A61K9/127
代理机构 代理人
主权项
地址
您可能感兴趣的专利